*

Penny Stock DD

Tag: xoma

MediciNova, Inc. (NASDAQ:MNOV) witnessed the correction of 25.28% and closed at $2.66 whereas overall traded volume stood at 1.68 million shares for the day. The current market price is 39.98% less than its last 50 days simple moving average. The share price is likely to move by 0.70 times against 1 point change in market index.

VIVUS, Inc. (NASDAQ:VVUS) went down by 0.46% to close at $6.54 with total traded volume of 1.30 million shares in the last trading day. Its outstanding share stood at 81.89 million and its total market capitalization ended at $535.56 million.

Novavax, Inc. (NASDAQ:NVAX) closed at $2.56 after dropping by 3.76% whereas traded volume stood at 1.10 million shares for the day. The share price is highly reactive to market index as its beta value stands at 2.25 times till its last trading session.

(Read the Rest of the Article…)

Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) jumped up by 28.57% to close at $1.71 with overall traded volume of 3.32 million shares in the last trading day. The company maintains strong short term liquidity position with current ratio of 4.47 times. The share price is likely to move by 1.43 times against 1 point change in market index.

XOMA Limited (NASDAQ:XOMA) went up by 8.98% and closed at $5.34 whereas total traded volume stood at 2.36 million shares for the day as compare to its average volume stood at 4.20 million shares. The shares price is highly reactive to market index as its beta value stands at 2 times till its last trading session.

(Read the Rest of the Article…)

More on this topic (What's this?) Read more on XOMA, Prana Biotechnology at Wikinvest

Xilinx, Inc. (NASDAQ:XLNX) moved up by 0.06% to close at $31.28 with overall traded volume of 5.62 million shares in the last trading day. The company maintains strong short term liquidity position with current ratio of 6.75 times. The current market price is 9.17% more than its more than its last 50 days simple moving average.

XOMA Limited (NASDAQ:XOMA) went down by 0.68% and closed at $5.82 whereas total traded volume stood at 1.24 million shares for the day. The share price is highly reactive to market index as its beta value stands at 2.03 times till its last trading session.

Yahoo! Inc. (NASDAQ:YHOO) closed at $15.97 after moving down by 1.63% with traded volume of 23.35 million shares. The current market price is 3.70% less than its last 50 days simple moving average. The share price is likely to move by 0.87 times against 1 point change in market index.

(Read the Rest of the Article…)

XOMA Limited (NASDAQ:XOMA) reported the fall of 14.01% and closed at $5.83 whereas overall traded volume stood at 13.93 million shares for the day. The share price is highly reactive to market index as its beta value stands at 2.03 times till its last trading session. The current market price is 83.40% more than its last 50 days simple moving average.

StemCells, Inc. (NASDAQ:STEM) moved down by 11.71% to close at $0.98 with total traded volume of 9.58 million shares in the last trading day. The company maintains strong short term liquidity position with current ratio of 5.53 times. The share price is at its oversold level with relative strength index of 35.43 times till its last trading session.  

(Read the Rest of the Article…)

NeuroMetrix, Inc. (NASDAQ:NURO) witnessed the correction of 8.98% to close at $0.54 with overall traded volume of 1.88 million shares in the last trading day. Its total market capitalization stood at $12.40 million. The company maintains strong short term liquidity position with current ratio of 724 times.

XOMA Limited (NASDAQ:XOMA) reported the fall of 8.76% and closed at $6.67 whereas total traded volume stood at 15.54 million shares for the day. The share price is highly sensitive as its beta value stands at 2.02 times till its last trading session. The current market price is 120.70% more than its last 50 days simple moving average.

(Read the Rest of the Article…)

XOMA

XOMA Limited (NASDAQ:XOMA) – Shares broke out on a bullish tear as XOMA announced their lead drug candidate XOMA 052 an antibody to interleukin-1 beta, an orphan drug for the treatment of Behcet’s disease, received FDA designation for Orphan Drug status. Shares reached an intraday high of $.395.

Regards,

Don

XOMA and CSGH up this week

September 27, 2009

Those Investors who may have watched some of our stock picks on pennystockdd.com may have seen a 20% increase in price this past week when XOMA hit $1.01 and CSGH hit a new 52 week high at $1.50.

We hope some of you may have profited from these moves. I continue to hold CSGH.

Good luck this coming trading week.

Regards,

Don

XOMA Announces $6 Million Antibody Discovery Collaboration With Arana Therapeutics

BERKELEY, Calif., Sep 9, 2009 – XOMA Ltd.  and Arana Therapeutics Limited, a wholly-owned subsidiary of Cephalon, Inc.  have entered into a collaboration involving multiple proprietary XOMA antibody research and development technologies, including a new antibody phage display library, and a suite of integrated information and data management systems. Arana has agreed to pay XOMA a fee of $6 million and XOMA will be entitled to milestone payments and royalties on product sales. Under the terms of the collaboration, XOMA will be fully reimbursed for all services it may provide to Arana under the agreement.

(Read the Rest of the Article…)

Regards,

Don

More on this topic (What's this?) Read more on XOMA, Raser Technologies at Wikinvest
Performance Optimization WordPress Plugins by W3 EDGE